Federal Circuit: System is Not a Method (and therefore patent must be delisted from Orange Book).

from Patently-O 1 year ago

by Dennis Crouch
Jazz Pharms, Inc. v. Avadel CNS Pharms, LLC (Fed.Cir.2023) In the pharmaceutical industry, there is a lot of interplay between the patents and FDA regulation.A party with an approved drug product will often list related patents in the Orange Book.Jazz's approved drug is sodium gamma-hydroxybutyrate ("GHB").

Read at Patently-O

#years #court-order #prescriptions

[

]

[

...

]

Federal Circuit: System is Not a Method (and therefore patent must be delisted from Orange Book).Federal Circuit: System is Not a Method (and therefore patent must be delisted from Orange Book). Briefly

Federal Circuit: System is Not a Method (and therefore patent must be delisted from Orange Book).
Federal Circuit: System is Not a Method (and therefore patent must be delisted from Orange Book).
Briefly